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Background: Following an exceptionally high Clostridium difficile infections (CDI) incidence (Spring 2011) in a
psychogeriatric long-term care facility, a bidirectional study (2009–2012) was initiated to identify determinants
(retrospectively) and to assess intervention measures taken (prospectively).
Methods: For every CDI patient (de novo cases, relapses, and recurrences), a control patient (patient in the opposite
room) was selected and risk factor analysis performed. Following the epidemic peak a more stringent hygienic
protocol and surveillance program were implemented, as well as uniform guidelines for metronidazole and
vancomycin prescription.
Results: The nutritional state (total protein/prealbumine) significantly differed between the CDI group (poorer
nutritional state at admission) and the control group, and also antibiotic use (general) could be confirmed as a risk
factor. A multi-disciplinary nutritional team has been established in order to improve the nutritional balance of our
patients.
Conclusions: Aside from stringent hygiene and antibiotic prescription stewardship, malnutrition of patients is a
factor to be taken into account to contain a CDI outbreak in a long term care facility (LTCF).
Keywords: Clostridium difficile, Intervention, Nutritional status, LTCFBackground
Clostridium difficile is an anaerobic Gram-positive, spore-
forming bacterium [1]. The ability of C. difficile to form
spores is thought to be a key feature in enabling the bac-
teria to persist in patients and in the physical environment
for long periods, thereby facilitating its transmission. C.
difficile is transmitted through the fecal-oral route. The
risk factors for acquiring C. difficile include contact with a
contaminated environment, contact with persons who are
infected with and shedding C. difficile, and ingestion of
contaminated food [2].
As the many spores formed by C. difficile are resistant
to most routine cleaning methods used on surfaces in
hospitals (except for diluted bleach), C. difficile infection
(CDI) has become the leading cause of diarrhea and* Correspondence: Boudewijn.Catry@wiv-isp.be
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unless otherwise stated.pseudomembranous colitis in healthcare settings [3]. There
is a strong connection between antimicrobial therapy and
CDI, as C. difficile can only colonize the gut if the normal
intestinal flora is disturbed or absent [3]. In recent years,
an increase in the incidence and the severity of healthcare-
associated CDI (nosocomial) has been reported worldwide.
This had been attributed to multiple factors including a
changing demographic situation, increased use of broad-
spectrum antibiotics and the emergence of hypervirulent
C. difficile strains. Outbreaks were associated with the
emergence and rapid spread of a specific strain of C. dif-
ficile belonging to the PCR-ribotype 027 or pulsotype
NAP1 (North American Pulsotype 1) [3]. Some of the
characteristics of this strain are higher in vitro production
of toxins A and B and presence of a third toxin named
binary toxin. Since about 2005, the epidemic strain has
started to circulate in northern Europe (United Kingdom,
Belgium and the Netherlands) [1].al. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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creased risk for adverse outcomes as a result of CDI. The
increased risk of acquiring CDI in the elderly may be due
to age-related changes in intestinal flora, immune senes-
cence, or the presence of other underlying diseases [3].
In Belgium, CDI incidence more than doubled be-
tween 1998 and 2007, after which it stabilized, be it at a
high level [4,5]. After an initial increase, the CDI mortal-
ity has been decreasing since 2004 [4]. PCR ribotype 027
was identified for the first time in 2003. Although strains
attributed to severe pathology are generally found in hos-
pital patients, recent reports suggest that the occurrence
and severity of CDI in the community is also increasing.
Moreover, CDI is more and more recognized as a cause of
diarrhea in populations previously considered to be at low
risk. The carriage ratio of C. difficile in the community-
dwelling elderly population in the UK is 4% [6]. The
patient population in the psychogeriatric institutions is
marked by cognitive impairment which hampers an op-
timal maintenance of standards of personal hygiene.
Patients are often unconscious of their hygienic condi-
tion and nursing staff regularly has to deal with non-
cooperative behavior regarding personal hygiene.
The long-term psychogeriatric facility, from which the
data in this manuscript are observed, had an increase of
CDI between 2009–2010 and 2012. However in the be-
ginning of 2011, a substantial increase of CDI episodes
was recorded in the institute. The objective of the manu-
script was to investigate underlying causes of this epi-
demic episode in order to identify the risk factors within




To identify risk factors for CDI, data covering the period
of January 2009 to December 2012 were retrospectively
abstracted from the patient’s record in four departments
of one psychogeriatric facility. The hospital had a total
capacity of 120 beds and the mean length of stay was
34 days. The effect was evaluated statistically.
B. Prospective design
To improve the CDI policy within institutions, an active
surveillance and prevention campaign (= intervention)
was launched during the epidemic peak in Spring 2011,
including hygiene precautions for health care professionals
and visitors. The effect was evaluated descriptively until
the end of the study period, namely December 2012.
Intervention
A more stringent hygienic protocol and surveillance pro-
gram were implemented in order to better battle the
current outbreak and to sooner detect potential futureoutbreaks: All CDI occurrences were reported back to a
single reference person and analyzed on a three-monthly
basis. When an increase by more than two standard
deviations above the normal background level was ob-
served, the following measures were taken: (a) staff was
alerted of the increased CDI incidence and the importance
of the existing hygienic measures was explicitly impressed
upon all personnel and visitors; (b) strict isolation mea-
sures were immediately taken for patients with diarrhea
awaiting the laboratory results on their fecal samples;
(c) patients with high suspicion for CDI (characteristic
odor and mucal composition of diarrhea) were immedi-
ately treated with metronidazole (p.o. 3 × 500 mg daily
for 10 days) or vancomycin (p.o. 4 × 125 mg daily for
10 days); (d) patients with confirmed CDI must have
been treated with vancomycin and were kept in isolation
during the full course of their CDI treatment (10 days for
de novo cases, 21 for relapses); (e) at the end of any CDI
treatment, patient rooms were cleaned with diluted bleach
(NaClO) prior to the standard disinfection procedure. This
cleaning procedure was once more repeated when the
concerned patient was discharged.
A request for ribotyping was submitted to the local
ethical committee (Number of acceptance: 2012/03/
09/2) in order to assess which strain was circulating
within the institution.
Upon approval (29 May 2012), a ribotyping was done
among all consecutive patients within the span of one year
(10 patients in total) in the aftermath of the 2011 peak.
Case definition & bacteriology
A Clostridium difficile infection (CDI) was defined if a
patient showed diarrhea as the major clinical symptom
and had a positive toxin/antigen test (C. diff quik chek
complete® - Alere Techlab) and a positive stool culture.
Cases were classified as (I) de novo case: no prior infec-
tion known; (II) relapse: CDI within 2 weeks after complet-
ing the treatment, and (III) late relapse (or recurrence):
CDI later than 2 weeks after completing the treatment.
C. difficile culture was performed according to local
standard procedures (CPG laboratory Brussels) (selective
media: CLO medium, incubation at 35° for 48 hours under
anaerobic conditions). Colonies were identified based on
Gram-staining, typical odor and chartreuse fluorescence
under ultraviolet light.
C. difficile isolates (only from the peak of 2011 onwards,
i.e. after initiation of intervention), were sent to the na-
tional reference laboratory [7] (UCL Brussels) for typing.
Strains were characterized by PCR-ribotyping, based on
the comparison of patterns of PCR products of the
16S–23S rRNA intergenic spacer regions using primers
described by Barbut et al. [8]. The size of each peak was
determined using GeneScan software or GeneMapper
V.4 software (AB - Applied Biosystems) [5].
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For all CDI episodes, patients’ files were reviewed (G VE).
For each patient, the patient in the opposite room served
as control. The parameters that were extracted are pre-
sented in Table 1.
The statistical analysis of the patient parameters was
performed based on the CDI incidence. This approach in-
herently applied the appropriate weight factor to the pa-
tient parameters of the more susceptible patients, as the
data for a patient who had two infections were counted
twice. All statistical analysis were performed either with
Microsoft Excel 2007 or with SPSS Statistics version 17.0.
(SPSS Inc, Chicago, IL). The t-test for independence and
Chi squared-test for nominal data were applied, with sig-
nificance level set at 0,05.Table 1 Overview of patient characteristics abstracted
from the medical records of Clostridium difficile cases
and controls in a long-term psychogeriatric health care
institute, Belgium 2011
General patient characteristics:
Age (years) at admission
Body Mass Index (BMI) (kg/m2) at admission
Frailty index (FI) at admission and at discharge according
to Drubbel et al. [9] (scaling between 1
and 0, 0 being perfectly healthy)
Nutritional status (mg/dL or g/L) at admission based on
prealbumine: (<20 mg/dl = malnutrition,
>20 mg/dL = normal). If not available,
based on total protein: <5,0 g/L
malnutrition, >5,0 g/L normal) [10]
Mini Mental State
Examination (MMSE)
(x/30) during stay to assess the cognitive
functioning. MMSE below 21/30 is a




(days), the date at which lab results
confirm the clinical diagnosis is taken
as the date of infection








Literature reported CDI risk factors:
Type of residency one month prior to admission, i.e.
previous health care exposure (acute
hospital, nursing home, LTCF)
Number and type
of antibiotics
used one month prior to CDI
Antacids used at admission (proton pump
inhibitor or histamin-2 blockers or none)
Number of narcotics used at admission
Diabetes mellitus type 2 at admission (yes/no)
CDI: Clostridium difficile infection; LTCF: long-term care facility.Results
A. Retrospective patient study
The study population consisted of 66 patients affected
by C. difficile and 61 control patients. A total of 94 epi-
sodes were included in the study: 42 patients had one
single episode of CDI during their hospitalization in the
institution and 24 patients relapsed or had a late relapse.
Among the latter, 20 patients had 2 episodes (16 relapses
and 4 late relapses), 3 patients with 3 episodes (4 relapses
and 2 late relapses), and 1 patient with 4 episodes of CDI
(3 relapses and 0 late relapses), respectively.
A baseline CDI incidence of 16 cases/1000 admissions
was found for the years 2009, 2010, and 2012, respect-
ively. Figure 1 shows the epidemic increase in the num-
ber of CDI cases in 2011. The increase included the
total number of CDI episodes, i.e. de novo cases, relapses
and late relapses.
The institution underwent an increased CDI incidence
as also reported by others during the same time frame in
Europe [12]. Once introduced, the highly infectious strain
spreads in-house: 42% of the relapses occurred for patients
in rooms previously occupied by an infected patient or in
adjacent rooms.
General patient characteristics
Table 2 gives the association comparing patients’ char-
acteristics of any CDI events and controls. The analysis
accounted for the fact that patients with a relapse would
have been counted more than once. Patients in the
infected group showed near-identical general character-
istics compared to patients in the control group. No dif-
ference was found regarding their mean age, body mass
index (BMI), frailty index or MMSE (Mini Mental State
Examination).
CDI specific characteristics
As discussed in the above section, especially during the
2011 CDI incidence peak, the institute had an important
influx of patients carrying the CDI. Of all positive cul-
tures, 18% were obtained within one week after admis-
sion and up to 25% within two weeks. We can assume
that the majority of the former had contracted C. diffi-
cile before admission in our hospital.
The mean length of stay for the control group was
55 days and for the CDI patient group 85 days. Logically,
the infection prolonged their mean length of stay, par-
tially due to the length of the CDI treatment itself, and
partially due to their weakened state thereafter requiring
additional care.
Figure 2 presents the antimicrobial treatment in func-
tion of case classification. The odds of relapse were 4,3
times (95% CI: 0,867 – 21,550) higher in patients treated
with metronidazole treatment compared to vancomycin
treatment. Metronidazole reduced sensitivity is known
Figure 1 Graphical overview of the incidence of Clostridium difficile infection (CDI) in a long-term psychogeriatric institution between
2009 and 2012, Belgium.
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was performed at the moment of the outbreak, this find-
ing suggested that we dealt with the same strain as the
one previously identified in the acute hospital setting.
The odds for relapse when comparing a short versus lon-
ger treatment, i.e. less than 14 days or more than 14 days,
showed no benefit for the longer treatment in our study
population (odds ratio = 0,9 (95% CI: 0,300 – 2,502)).
The mortality in the CDI group was 21% compared to
10% in the control group.
Literature reported CDI risk factors
Since literature reported CDI risk factors, as selected for
this study, have all been evaluated at admission, we have
chosen to perform this statistical analysis based on the
data per patient rather than per CDI incidence event. An
overview of the statistical analysis is shown in Table 3.
From the risk factors previously discussed in literature,
only antibiotic use differs significantly between the con-
trol group and the CDI patients in our study population.Table 2 Comparison of patients’ characteristics of Clostridium
Controls
Mean St. Dev. Range
Age (years) 82 7,3 (64–99)
BMI (kg/m2) 23 5,1 (15–37)
FI-admission 0,38 0,09 (0,25-0,55)
total protein (g/L) 5,8 0,9 (4–8)
Prealbumine (mg/dL) 20,6 7 (8–35)
MMSE (x/30) 22 6 (7–30)
§p-value: from independent t-test; *: significant at p<0,05.
For abbreviations: see Table 1.B. Prospective CDI policy improvement
Although hygienic procedures were available at the mo-
ment of the outbreak, raising awareness and improved
internal communication were the first steps to be under-
taken. Figure 3 shows that the implementation of the infec-
tion control measures (May-June 2011) coincided with a
significant drop in CDI incidence. Although the epidemio-
logical characteristics combined with the metronidazole re-
duced sensitivity strongly point towards infections with the
027 strain, ribotyping was not able to confirm this suspi-
cion, given the time delay between the outbreak and the
approval from the ethical committee.
Upon approval of the request (May 2012), all consecu-
tive patients (n = 10) within the time frame of one year,
were ribotyped, but no 027 strain was confirmed in any
of these samples. Reassuringly, these findings substantiate
the effectiveness of the more stringent hygienic protocol
for battling an infectious outbreak.
The patient parameter study has led to two additional
measures; (a) guidelines for metronidazole and vancomycindifficile infection (CDI) events and controls
CDI infections p-value§
Mean St. Dev. Range
82 7 (66–97) 0,77
23 5,5 (15–40) 0,88
0,38 0,07 (0,22-0,53) 0,62
5,4 0,8 (4–8) 0,03*
16,6 7,4 (5–41) 0,03*
21 7,3 (0–30) 0,68
Figure 2 Vancomycin (blue) or metronidazole (green) treatment counts for Clostridium difficile infections (CDI), separated between
relapse and non-relapse cases.
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above, and (b) if malnutrition appears to be an underlying
problem and a possible additional risk-factor, a multi-
disciplinary nutritional team, consisting of a psychologist,
dietician and physiotherapist is established in order to im-
prove the nutritional balance of the patients.
Discussion
Only the nutritional status, based on the total protein
and prealbumine levels, was found to be significantly
poorer for the patients that suffered CDI: whereas patients
in the control group on average were classified as normal
(mean prealbumine >20 mg/dL), patients in the infected
group already suffered from malnutrition at admission
(mean prealbumine < 20 mg/dL). Their total protein level
was also significantly lower. A multi-disciplinary nutri-
tional team thus can be considered in long term care facil-
ities to further contain C. difficile outbreaks.
Within the general patient characteristics, the frailty
index was higher than reported by Drubbel et al. [9].
They reported a median FI score of 0,08 for women
and 0,06 for men. Our median FI was 0,39. A slight
discrepancy could arise from the fact that we calcu-
lated the FI manually, based on the patients files and not
automatically as done by Drubbel and her group.
However, the main difference is related to the patient
population itself: in contrast to their study population
(community-dwelling elderly people), here we only
focused on inpatients.
To our knowledge, there is only one study evaluating
cognitive impairment in relation with CDI. Kyne et al.
[14] reported in 1999 that cognitive impairment is a risk
factor for severity of CDI. Although here, we alsohypothesized that cognitive impairment might be an
additional risk factor for contracting or developing CDI,
our data did not support this hypothesis: no difference
was observed between the MMSE data of both groups.
Given the high frailty index (FI) in the population of our
study, it should be noted that both groups are dependent
on the same external help for their hygienic situation,
independent of their cognitive state. Thirty-eight percent
of our C. difficile patients and 36% of our control
patients went to a nursing home after discharge.
Regarding the CDI specific parameters, we noticed an
overall mortality rate of 21% in our CDI group. This
number is in the range of other mortality rates published
before [15,16]. As we did not calculate the attributable
mortality of CDI, we probably overestimate the CDI mor-
tality rate because we did not correct for other factors like
high age and multiple underlying diseases [17].
The increasing incidence and severity of CDI is largely
described in literature [12]. Viseur et al. published the
surveillance data for Belgium from 2008 to 2010 [5]. Data
from these years showed a relatively stable incidence of
CDI in Belgian hospitals, with a slight decrease in 2010.
Surveillance data until 2011 are available on the website of
the Public Health and Surveillance Department, Scientific
Institute for Public Health (WIV-ISP), Brussels [4]. The
overall incidence of CDI in 2011 is comparable with 2010,
but between 2007 and 2011, there were more outbreaks of
CDI in long-term care hospitals than in the acute hospital
setting (60% vs. 38%). Our data fits within this trend.
The background incidence (16 CDI per 1000 admission)
is comparable to the data reported by Mascart et al. in a
geriatric department (Centre Hospitalier Universitaire
Brugmann, Brussels), located in the same geographic area
Table 3 Statistical analysis of the literature reported
Clostridium difficile infection (CDI) risk factors for all
patients in the study
Controls CDI patients p-value
No. % No. %
Previous health care exposure 53/61 87 64/66 97 0,152
• Acute hospital 52/53 98 62/64 97
• Nursing home 1/53 2 1/64 1,5
• LTCFa 0/53 0 1/64 1,5
Any antibiotic use during
1 month preceding
symptom onset
33/52 63 58/66 88 0,001*
• Clindamycin 1/49 2 2/84 2,3
• Fluoroquinolones 7/49 14 13/84 15,4
• Amoxicillin–clavulanic acid 22/49 45 36/84 43
• Otherb 19/49 39 33/84 39
Antacids use at admission 39/55 71 48/57 84 0,138
• Histamine 2-blocker 5/39 13 3/48 6
• Proton-pump inhibitor (PPI) 34/39 87 45/48 94
Number of narcotics at admission 47/53 89 48/58 83 0,832
• 1 narcotic 21/47 45 17/48 35
• 2 narcotics 15/47 32 16/48 33
• 3 narcotics 7/47 15 11/48 23
• 4 narcotics 3/47 6 3/48 6
• 5 narcotics 1/47 2 1/48 2
Diabetes mellitus 14/57 25 11/64 17 0,317
aLTCF: long-term care facility.
b’other’ includes cephalosporins, tetracyclines, macrolides and
cotrimoxazole (trimethoprim + sulphonamides).
The last column reports the p-value of Chi2-test for nominal data. The values
marked with the asterix are significant at the 0,05 level.
Figure 3 Graphical overview of the monthly incidence of Clostridium
awareness moment with communication of increase in incidence. Line 2: F
and uniform antibiotic guidelines.
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in 2008 and 21/1000 admissions in 2009. The ribotype
027 was the most prevalent ribotype during the years
2007–2009. Unfortunately no recent data are available to
support the hypothesis of the ribotype 027 involvement in
outbreaks among patients in geriatric wards.
Based upon experience, vancomycin could be recom-
mended as the first-line agent to protect against recurrence
and control of a hospital outbreak caused by a hyperviru-
lent strain. Control is difficult but possible through a com-
bination of barrier precautions, environmental cleaning,
and antimicrobial stewardship, interventions that all are
concordant with literature [13,15].Conclusions
In summary, following the 2011 CDI outbreak in the
institution in which the study was conducted a more
stringent hygienic protocol and surveillance program
were implemented in order to sooner detect potential
outbreaks. Additionally, uniform guidelines for metro-
nidazole and vancomycin prescription have been imple-
mented. Finally, a multi-disciplinary nutritional team
has been established in order to improve the nutritional
balance of our patients.Ethical standards
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